These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10734823)

  • 1. Study supports medication for ADHD.
    Health News; 2000 Feb; 6(2):5. PubMed ID: 10734823
    [No Abstract]   [Full Text] [Related]  

  • 2. [Basics of the drug therapy for attention deficit hyperactivity disorders in adolescents].
    Airaksinen E; Airaksinen MM
    Duodecim; 2003; 119(16):1553-62. PubMed ID: 14535028
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder.
    Staller JA; Faraone SV
    Expert Rev Neurother; 2007 Apr; 7(4):351-62. PubMed ID: 17425490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.
    Volkow ND; Wang GJ; Fowler JS; Ding YS
    Biol Psychiatry; 2005 Jun; 57(11):1410-5. PubMed ID: 15950015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study.
    Ludolph AG; Kassubek J; Schmeck K; Glaser C; Wunderlich A; Buck AK; Reske SN; Fegert JM; Mottaghy FM
    Neuroimage; 2008 Jul; 41(3):718-27. PubMed ID: 18424180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder.
    Han DH; Lee YS; Na C; Ahn JY; Chung US; Daniels MA; Haws CA; Renshaw PF
    Compr Psychiatry; 2009; 50(3):251-6. PubMed ID: 19374970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention-deficit/hyperactivity disorder: a personal perspective.
    Ginsberg ML
    Adolesc Med State Art Rev; 2008 Aug; 19(2):339-51, xi-xii. PubMed ID: 18822837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
    Fone KC; Nutt DJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
    't Jong GW; van den Anker JN
    Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263
    [No Abstract]   [Full Text] [Related]  

  • 13. ADHD drugs and cardiovascular risk.
    Wojnowski L
    N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729376
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of methylphenidate in children with ADHD].
    Lauth B
    Laeknabladid; 2007 Dec; 93(12):823. PubMed ID: 18057471
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
    Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
    Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ADHD 6-year-old child ultrarapid metabolizer for CYP2D6.
    Bonnet-Brilhault F; Broly F; Blanc R; Furet Y; Barthélémy C; Paintaud G
    J Clin Psychopharmacol; 2006 Aug; 26(4):442-4. PubMed ID: 16855474
    [No Abstract]   [Full Text] [Related]  

  • 18. [Central stimulants in the treatment of children with ADHD: unknown long-term effect and uncertain pharmacological documentation].
    Zetterström R
    Lakartidningen; 2002 Feb; 99(7):677-80. PubMed ID: 11887717
    [No Abstract]   [Full Text] [Related]  

  • 19. ADHD, Ritalin, and big brother.
    Miller AL
    Altern Med Rev; 2000 Oct; 5(5):401. PubMed ID: 11056410
    [No Abstract]   [Full Text] [Related]  

  • 20. Transdermal methylphenidate (Daytrana) for ADHD.
    Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.